Evaluating dynamic impacts of abuse-deterrent prescription opioid formulations.
暂无分享，去创建一个
[1] M. Brandeau,et al. Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic , 2018, American journal of public health.
[2] R. Bruno,et al. Post‐marketing studies of pharmaceutical opioid abuse‐deterrent formulations: a framework for research design and reporting , 2018, Addiction.
[3] D. Fiellin,et al. Abuse-Deterrent Opioid Formulations - Putting the Potential Benefits into Perspective. , 2017, The New England journal of medicine.
[4] M. Lynch. The need for a Canadian pain strategy. , 2011, Pain research & management.